Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis

Autor: Harriet, Corvol, Sandra, de Miranda, Clémence, Dehillotte, Lydie, Lemonnier, Raphael, Chiron, Isabelle, Danner-Boucher, Rebecca, Hamidfar, Véronique, Houdouin, Julie, Macey, Christophe, Marguet, Marlène, Murris-Espin, Quitterie, Reynaud, Philippe, Reix, Martine Reynaud, Gaubert, Astrid, Kemgang, Pierre-Régis, Burgel

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are closely monitored in people with cystic fibrosis (pwCF), with a special emphasis on severe cases. Previous studies used hospitalization rates as proxy for severity.We evaluat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7b70e8d509df222bbd9d26eccf92ca3e
https://pubmed.ncbi.nlm.nih.gov/35475917

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis

Autor: Christophe Corpechot, Olivier Chazouillères, Astrid Kemgang, Sarah Jegou, Marjolène Straube, Karima Ben Belkacem, Chantal Housset, Sara Lemoinne, Harry Sokol

Publikováno v: Gut
Gut, BMJ Publishing Group, 2019, pp.gutjnl-2018-317791. ⟨10.1136/gutjnl-2018-317791⟩
Gut, 2019, pp. gutjnl-2018-317791. ⟨10.1136/gutjnl-2018-317791⟩
Journal of Hepatology
International Liver Congress / 54. Annual Meeting of the
International Liver Congress / 54. Annual Meeting of the, European Association for the Study of the Liver (EASL). CHE., Apr 2019, Vienne, Austria. ⟨10.1016/S0618-8278(19)30138-0⟩

ObjectivePatients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this study was to assess the fungal gut microbiota in p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb68b783b0025b5c5cb1a9dc67fcd9ea
https://hal.sorbonne-universite.fr/hal-02116096/document

Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy

Autor: Yves Menu, Astrid Kemgang, Véronique Miette, Céline Fournier, Olivier Golsztejn, Christophe Corpechot, Farid Gaouar, Laurent Sandrin, Magali Sasso, Stephane Audiere, Stéphane Prince, Olivier Chazouillères

Publikováno v: Ultrasound in Medicine & Biology. 42:92-103

To assess liver steatosis, the controlled attenuation parameter (CAP; giving an estimate of ultrasound attenuation ∼3.5 MHz) is available with the M probe of the FibroScan. We report on the adaptation of the CAP for the FibroScan XL probe (center f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fadb96a8eb231f876ea64d52b76c2d72
https://doi.org/10.1016/j.ultrasmedbio.2015.08.008

Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study

Autor: Christine Sempoux, Roger W. Chapman, Valérie Paradis, Ben Vainer, Benjamin Goeppert, Cyriel Y. Ponsioen, Astrid Kemgang, Peter Schirmacher, Stefan G. Hübscher, Kate D. Williamson, Annette S. H. Gouw, Johanna Arola, Joanne Verheij, Ulrich Beuers, Olivier Chazouillères, Katharina Biermann, Maren H. Harms, Gideon M. Hirschfield, Martti Färkkilä, Daniel Gotthardt, Elisabeth M.G. de Vries, Dominique Wendum, Henk R. van Buuren, Henriette Ytting, Palak J. Trivedi, Lai Mun Wang, Manon de Krijger

Publikováno v: Hepatology, 65(3), 907-919. Wiley
Hepatology, 65(3), 907-919. John Wiley & Sons Ltd.
Hepatology (Baltimore, Md.), 65(3), 907-919. John Wiley and Sons Ltd

Histologic scoring systems specific for primary sclerosing cholangitis (PSC) are not validated. We recently determined the applicability and prognostic value of three histological scoring systems in a single PSC cohort. The aim of this study was to v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e6a17401ee394e9382abea197635534
https://ora.ox.ac.uk/objects/uuid:08afcfff-57cf-4f56-b886-dac84a152354

No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients With Primary Sclerosing Cholangitis

Autor: Karouk Said, Schalk Van der Merwe, Paolo Cantù, Olivier Chazouillères, Vemund Paulsen, Lars Aabakken, Douglas Thorburn, Annika Bergquist, Stephen P. Pereira, Kim N. van Munster, Per Ove Stotzer, Hanns-Ulrich Marschall, Astrid Kemgang, I. Parzanese, Werner Van Steenbergen, Benoit Desaint, Martti Färkkilä, Elisabeth M.G. de Vries, Urban Arnelo, Cyriel Y. Ponsioen, Erik A.J. Rauws

Publikováno v: Gastroenterology, 155(3), 752-759.e5. W.B. Saunders Ltd

BACKGROUND & AIMS: Dominant strictures occur in approximately 50% of patients with primary sclerosing cholangitis (PSC). Short-term stents have been reported to produce longer resolution of dominant strictures than single-balloon dilatation. We perfo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e5bd5dad513472e14525632ba4205f
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85051833978&origin=inward